Stocks and Investing Stocks and Investing
Thu, December 16, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Sean Steuart Upgraded (BEP) to Strong Buy and Held Target at $41 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Toni Kaplan Maintained (BFAM) at Sell with Decreased Target to $111 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Bryan Bergin Maintained (ACN) at Buy with Increased Target to $430 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
David Grossman Maintained (ACN) at Strong Buy with Increased Target to $440 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Moshe Katri Maintained (ACN) at Buy with Increased Target to $450 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Daniel Perlin Maintained (ACN) at Buy with Increased Target to $430 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Brad Erickson Downgraded (ABNB) to Hold and Decreased Target to $175 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Kash Rangan Initiated (ZM) at Hold and Held Target at $200 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Matthew Harrison Initiated (BNTX) at Hold and Held Target at $294 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Brian Johnson Maintained (BWA) at Hold with Increased Target to $49 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Beth Reed Initiated (BURL) at Strong Buy and Held Target at $350 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Vivek Juneja Upgraded (BK) to Buy and Increased Target to $67 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Brad Erickson Upgraded (BKNG) to Buy on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Casey Orr Whitman Upgraded (AUB) to Buy and Increased Target to $42 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Mark Delaney Initiated (AUR) at Hold and Held Target at $13 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Meta Marshall Maintained (BAND) at Hold with Decreased Target to $85 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
James Lee Maintained (BABA) at Strong Buy with Decreased Target to $245 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Mark Jarvi Initiated (AY) at Hold and Held Target at $41 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Ned Baramov Maintained (AM) at Hold with Increased Target to $12 on, Dec 16th, 2021
[ Thu, Dec 16th 2021 ] - WOPRAI
Brian Johnson Maintained (ALV) at Buy with Increased Target to $115 on, Dec 16th, 2021
Wed, December 15, 2021
[ Wed, Dec 15th 2021 ] - WOPRAI
Joseph Moore Maintained (AMAT) at Hold with Increased Target to $160 on, Dec 15th, 2021
[ Wed, Dec 15th 2021 ] - WOPRAI
George Staphos Upgraded (AMCR) to Strong Buy and Held Target at $13 on, Dec 15th, 2021
[ Wed, Dec 15th 2021 ] - WOPRAI
Thomas Yeh Maintained (AMCX) at Hold with Decreased Target to $43 on, Dec 15th, 2021
[ Wed, Dec 15th 2021 ] - WOPRAI
Jeffrey Bernstein Maintained (CAKE) at Sell with Decreased Target to $37 on, Dec 15th, 2021
[ Wed, Dec 15th 2021 ] - WOPRAI
Michael Ulz Maintained (CABA) at Buy with Decreased Target to $15 on, Dec 15th, 2021
[ Wed, Dec 15th 2021 ] - WOPRAI
Dick Bove Upgraded (C) to Strong Buy and Held Target at $69 on, Dec 15th, 2021
[ Wed, Dec 15th 2021 ] - WOPRAI
Michael Rehaut Upgraded (AZEK) to Buy and Held Target at $56 on, Dec 15th, 2021
[ Wed, Dec 15th 2021 ] - WOPRAI
James Faucette Maintained (AXON) at Buy with Decreased Target to $180 on, Dec 15th, 2021
[ Wed, Dec 15th 2021 ] - WOPRAI
Seth Seifman Maintained (BA) at Buy with Decreased Target to $270 on, Dec 15th, 2021
[ Wed, Dec 15th 2021 ] - WOPRAI
Corinne Jenkins Initiated (ATHA) at Hold and Held Target at $16 on, Dec 15th, 2021

Corinne Jenkins Initiated (ATHA) at Hold and Held Target at $16 on, Dec 15th, 2021


Published on 2024-10-27 19:00:06 - WOPRAI, Corinne Jenkins
  Print publication without navigation


Corinne Jenkins of Goldman Sachs, Initiated "Athira Pharma, Inc." (ATHA) at Hold and Held Target at $16 on, Dec 15th, 2021.

Corinne, nor any peers, have made any analyst calls on ATHA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources